These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 24118466)

  • 1. Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study.
    Stuijver DJ; Piantanida E; van Zaane B; Galli L; Romualdi E; Tanda ML; Meijers JC; Büller HR; Gerdes VE; Squizzato A
    Haemophilia; 2014 May; 20(3):326-32. PubMed ID: 24118466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II.
    Heilmann C; Trummer G; Beyersdorf F; Brehm K; Berchtold-Herz M; Schelling J; Geisen U; Zieger B
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):587-590. PubMed ID: 28082469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study.
    Tiede A; Priesack J; Werwitzke S; Bohlmann K; Oortwijn B; Lenting P; Eisert R; Ganser A; Budde U
    J Thromb Haemost; 2008 Apr; 6(4):569-76. PubMed ID: 18208537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing a method for in vitro investigation of mechanical parameters causing acquired von Willebrand syndrome in ventricular assist devices.
    Egger C; Maas J; Hufen T; Schmitz-Rode T; Steinseifer U
    Artif Organs; 2013 Sep; 37(9):833-9. PubMed ID: 23834027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine.
    Michiels JJ; Schroyens W; Berneman Z; van der Planken M
    Clin Appl Thromb Hemost; 2001 Apr; 7(2):113-5. PubMed ID: 11292187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired von Willebrand syndrome in adult patients with congenital heart disease.
    Waldow HC; Westhoff-Bleck M; Widera C; Templin C; von Depka M
    Int J Cardiol; 2014 Oct; 176(3):739-45. PubMed ID: 25139318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired von Willebrand syndrome associated with hypothyroidism: a mild bleeding disorder to be further investigated.
    Federici AB
    Semin Thromb Hemost; 2011 Feb; 37(1):35-40. PubMed ID: 21305800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
    Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F
    Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of inhibitors in acquired von Willebrand syndrome.
    Mohri H; Motomura S; Kanamori H; Matsuzaki M; Watanabe S; Maruta A; Kodama F; Okubo T
    Blood; 1998 May; 91(10):3623-9. PubMed ID: 9572997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Acquired von Willebrand Syndrome in Cardiopulmonary Disorders: Do Laboratory Abnormalities Predict Bleeding Risk?
    Hashmi SK; Velasquez MP; Yee DL; Hui SK; Mahoney D; Srivaths LV
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):121-125. PubMed ID: 28060126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand Syndrome.
    Franchi F; Biguzzi E; Stufano F; Siboni SM; Baronciani L; Peyvandi F
    Thromb Res; 2014 Dec; 134(6):1316-22. PubMed ID: 25300810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired von Willebrand syndrome in patients with Gaucher disease.
    Mitrovic M; Elezovic I; Miljic P; Suvajdzic N
    Blood Cells Mol Dis; 2014 Apr; 52(4):205-7. PubMed ID: 24275154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.
    Goda M; Jacobs S; Rega F; Peerlinck K; Jacquemin M; Droogne W; Vanhaecke J; Van Cleemput J; Van den Bossche K; Meyns B
    J Heart Lung Transplant; 2013 May; 32(5):539-45. PubMed ID: 23570742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin.
    Graf L; Moffat KA; Carlino SA; Chan AK; Iorio A; Giulivi A; Hayward CP
    Int J Lab Hematol; 2014 Jun; 36(3):341-51. PubMed ID: 24750681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired von Willebrand syndrome: data from an international registry.
    Federici AB; Rand JH; Bucciarelli P; Budde U; van Genderen PJ; Mohri H; Meyer D; Rodeghiero F; Sadler JE;
    Thromb Haemost; 2000 Aug; 84(2):345-9. PubMed ID: 10959711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome.
    Stufano F; Boscarino M; Bucciarelli P; Baronciani L; Maino A; Cozzi G; Peyvandi F
    Semin Thromb Hemost; 2019 Feb; 45(1):36-42. PubMed ID: 29913537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome.
    van Genderen PJ; Boertjes RC; van Mourik JA
    Thromb Haemost; 1998 Sep; 80(3):495-8. PubMed ID: 9759633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.